Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Rio Drug-Testing Lab Loses WADA Accreditation as World Cup Nears

Aug. 27 (Bloomberg) -- The drug-testing laboratory that would be responsible for Olympic and soccer World Cup testing in Rio de Janeiro had its accreditation revoked by the World Anti-Doping Agency.

The LAB DOP-LADETEC/IQ-UFRJ Doping Control Laboratory, known as LADETEC, will no longer be authorized to carry out any anti-doping activities for WADA, which announced the decision today in an e-mailed statement. The penalty takes effect Sept. 25.

WADA didn’t elaborate on why the lab’s accreditation was revoked, other than saying it didn’t meet the requirements of the International Standard for Laboratories. This is the second time that LADETEC has fallen below those standards, according to the statement, and the lab was suspended for nine months in January 2012 before being reinstated.

Today’s news comes three weeks after Montreal-based WADA announced the lab’s accreditation was suspended. WADA’s executive committee made the decision to revoke the accreditation after a review by its disciplinary panel.

LADETEC can appeal the decision to the Court of Arbitration for Sport within the next 21 days, according to the release. It can also choose to reapply for accreditation through a fast-track process from the executive committee.

The only remaining South American WADA-accredited lab for doping control analysis is based in Bogota. There are 32 worldwide, not including LADETEC.

The World Cup begins June 12, 2014, and the Olympics will be held in Rio in 2016.

To contact the reporters on this story: Eben Novy-Williams in New York at enovywilliam@bloomberg.net

To contact the editor responsible for this story: Michael Sillup at msillup@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.